Drug profile · INN
clobetasol propionate
CLOBETASOL PROPIONATE
clobetasol propionate (CLOBETASOL PROPIONATE) is a glucocorticoid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — clobetasol propionate
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 3
- Data quality
- 0.89
Quick answer
clobetasol propionate (CLOBETASOL PROPIONATE) is a glucocorticoid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is clobetasol propionate?
clobetasol propionate (CLOBETASOL PROPIONATE) is a glucocorticoid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for clobetasol propionate?
CLOBETASOL PROPIONATE is a marketed brand name for clobetasol propionate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clobetasol propionate?
clobetasol propionate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.